Tech Company Financing Transactions
Theron Pharmaceuticals Funding Round
The Halo Funds participated in a $407 thousand funding round for Theron Pharmaceuticals. The round was announced on 6/30/2010.
Transaction Overview
Company Name
Announced On
6/30/2010
Transaction Type
Venture Equity
Amount
$407,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
365 San Aleso Ave.
Sunnyvale, CA 94085
USA
Sunnyvale, CA 94085
USA
Phone
Website
Email Address
Overview
Founded in 2008, Theron Pharmaceuticals is a privately held biotechnology company developing a best-in-class, long acting M3 muscarinic antagonist (LAMA) for the improved treatment of chronic respiratory diseases such as chronic obstructive pulmonary disease (COPD) and severe asthma.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jurg Pfister
Co-Founder
Venkat Venkatraman
Co-Founder
Xiaoming Zhang
Browse more venture capital transactions:
Prev: 6/30/2010: Empire Water venture capital transaction
Next: 6/30/2010: Symphony 3D Technologies venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to record every notable VC transaction. VC transactions reported here come from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs